Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02726217 · ClinicalTrials.gov registry record · NA
NYULMC CareSmarts Pilot
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02726217 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 26 participants.
The verdict
NCT02726217, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
CareSmarts is a theory-driven behavioral intervention designed to improve self-care among patients with Type 2 diabetes (T2D) with poor glycemic control (HbA1c\>8%), through multiple mediators, including cuing, education, self-efficacy, social support, and health beliefs. Individuals will be randomly assigned with equal allocation to either the CareSmarts intervention or to usual care for 6 months.
Interventions
- BEHAVIORAL CareSmarts Mobile Health Diabetes Program
- BEHAVIORAL Standard of Care Reminders and Self Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2017-05-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02726217
The ClinicalTrials.gov registry entry for NCT02726217 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CareSmarts Mobile Health Diabetes Program is the first listed.
NCT02726217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02726217 about?
NCT02726217 is a clinical study titled "NYULMC CareSmarts Pilot". CareSmarts is a theory-driven behavioral intervention designed to improve self-care among patients with Type 2 diabetes (T2D) with poor glycemic control (HbA1c\>8%), through multiple mediators, including cuing, education, self-efficacy, social support, and health beliefs. Individuals will be randoml...
What is the current status of trial NCT02726217?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2016-03-01. Estimated completion is 2017-05-02.
What interventions are being tested in trial NCT02726217?
The interventions under investigation include: CareSmarts Mobile Health Diabetes Program (BEHAVIORAL), Standard of Care Reminders and Self Assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT02726217?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.